Literature DB >> 19204067

Human ESC-derived neural rosettes and neural stem cell progression.

Y Elkabetz1, L Studer.   

Abstract

Neural stem cells (NSCs) are defined by their ability to self-renew while retaining differentiation potential toward the three main central nervous system (CNS) lineages: neurons, astrocytes, and oligodendrocytes. A less appreciated fact about isolated NSCs is their narrow repertoire for generating specific neuron types, which are generally limited to a few region-specific subtypes such as GABAergic and glutamatergic neurons. Recent studies in human embryonic stem cells have identified a novel neural stem cell stage at which cells exhibit plasticity toward generating a broad range of neuron types in response to appropriate developmental signals. Such rosette-stage NSCs (R-NSCs) are also distinct from other NSC populations by their specific cytoarchitecture, gene expression, and extrinsic growth requirements. Here, we discuss the properties of R-NSCs within the context of NSC biology and define some of the key questions for future investigation. R-NSCs may represent the first example of a NSC population capable of recreating the full cellular diversity of the developing CNS, with implications for both basic stem cell biology and translational applications in regenerative medicine and drug discovery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19204067     DOI: 10.1101/sqb.2008.73.052

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  49 in total

Review 1.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

Review 2.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 3.  Embryonic stem cell application in drug discovery.

Authors:  Yi-jia Lou; Xing-guang Liang
Journal:  Acta Pharmacol Sin       Date:  2011-01-10       Impact factor: 6.150

Review 4.  Programming embryonic stem cells to neuronal subtypes.

Authors:  Mirza Peljto; Hynek Wichterle
Journal:  Curr Opin Neurobiol       Date:  2010-10-20       Impact factor: 6.627

5.  Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response.

Authors:  Inna Lipchina; Yechiel Elkabetz; Markus Hafner; Robert Sheridan; Aleksandra Mihailovic; Thomas Tuschl; Chris Sander; Lorenz Studer; Doron Betel
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

6.  Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencing.

Authors:  Jia Qian Wu; Lukas Habegger; Parinya Noisa; Anna Szekely; Caihong Qiu; Stephen Hutchison; Debasish Raha; Michael Egholm; Haifan Lin; Sherman Weissman; Wei Cui; Mark Gerstein; Michael Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

Review 7.  Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders.

Authors:  Flora M Vaccarino; Hanna E Stevens; Arif Kocabas; Dean Palejev; Anna Szekely; Elena L Grigorenko; Sherman Weissman
Journal:  Neuropharmacology       Date:  2011-03-01       Impact factor: 5.250

8.  Interaction of p53 and ASPPs regulates rhesus monkey embryonic stem cells conversion to neural fate concomitant with apoptosis.

Authors:  Shuang Wang; Lichuan Yang; Raoxian Bai; Shuaiwei Ren; Yuyu Niu; Yuanye Ma; Weizhi Ji; Yongchang Chen
Journal:  Cell Cycle       Date:  2018-07-25       Impact factor: 4.534

Review 9.  Endodermal stem cell populations derived from pluripotent stem cells.

Authors:  Xin Cheng; Amita Tiyaboonchai; Paul Gadue
Journal:  Curr Opin Cell Biol       Date:  2013-02-26       Impact factor: 8.382

Review 10.  Important precautions when deriving patient-specific neural elements from pluripotent cells.

Authors:  Xuejun H Parsons; Yang D Teng; Evan Y Snyder
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.